• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Newly Discovered Arenavirus: Chapare

mixin

Well-known member
http://www.news-medical.net/?id=37477
A team of Bolivian health authorities, U.S. Navy health experts based in Lima, Peru, and the U.S. Centers for Disease Control and Prevention has characterized "Chapare arenavirus," a previously unrecognized arenavirus, discovered in serum samples from a patient in rural Bolivia who eventually died of the infection.

Named after the Chapare River in the eastern foothills of the Andes, the new Chapare arenavirus produces clinical hemorrhagic symptoms similar to those associated with other New World arenaviruses, such as the Junin, Machupo, Guanarito, and Sabia viruses. Genetically, however, Chapare is different from each.

Junin, Machupo and Guanarito viruses have been associated with large outbreaks of hemorrhagic fever. Initial symptoms often include fever, malaise, muscle aches, nausea, vomiting, and anorexia, followed later by hemorrhagic symptoms. Untreated, more severe neurologic and/or hemorrhagic symptoms may develop, and death occurs in up to 30%.

In this study, the authors first tested for yellow fever and dengue hemorrhagic fevers, but results were negative. Tests for Machupo and other related viruses also were negative. Sequence analysis of specific segments of the virus later confirmed it as a unique member of the Clade B New World Arenaviruses.

Due to the remote nature of the region where the case occurred, only a limited description of a possible cluster of cases in the area was determined.

"Further surveillance and ecological investigations should clarify the nature of the health threat posed by the Chapare virus, and give us better information on the source of human infection," says CDC virologist Tom Ksiazek of the Special Pathogens Branch.

"We need to learn more about this virus: how it is related to the other arenaviruses, how it causes disease, where it lives in nature," says Ksiazek. "Together with our colleagues in Bolivia and Peru, we're anticipating a more intensive investigation that improves our understanding of the virus, the disease it causes, and its ecology."

The full study can be found here:
http://www.plospathogens.org/articl...7;jsessionid=AB804907E1443AFEA03A5AC835DAFF08
 
Back
Top Bottom